Medpace Holdings (MEDP) Long-Term Deferred Tax (2015 - 2026)

Medpace Holdings (MEDP) has 12 years of Long-Term Deferred Tax data on file, last reported at $3.2 million in Q2 2026.

• Quarterly Long-Term Deferred Tax fell 95.09% year-over-year to $3.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $3.2 million (down 95.09% YoY) and the FY2025 annual result came in at $19.2 million, down 80.85% from the prior year.
• Long-Term Deferred Tax steadied at $3.2 million in Q2 2026, from $3.2 million in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $100.4 million in Q4 2024 to a low of $3.2 million in Q1 2026.
• A 5-year average of $51.0 million and a median of $50.5 million in 2023 frame the typical range for Long-Term Deferred Tax.
• Annual changes were most pronounced in 2022 — Long-Term Deferred Tax surged 4796.48% — and 2026, when it sank 96.77%.
• Tracing MEDP's Long-Term Deferred Tax over 5 years: stood at $48.1 million in 2022, then jumped by 54.81% to $74.4 million in 2023, then surged by 34.83% to $100.4 million in 2024, then tumbled by 80.85% to $19.2 million in 2025, then plunged by 83.19% to $3.2 million in 2026.
• The last three Long-Term Deferred Tax figures came in at $3.2 million (Q2 2026), $3.2 million (Q1 2026), and $19.2 million (Q4 2025), per Business Quant data.